B cell trafficking is influenced by many chemokines, including CXCL13, which is elevated in MS patients, correlating with the increased B cell numbers, as well as with conversion from clinically isolated syndrome (CIS) to definitive MS [207]. Here, CXCL13 is linked to myeloid sarcoma.